Nevertheless, the treatment of ATXN3 knockout colon cancer cells with the proteasomal inhibitor MG132 completely restored Galectin-9 protein expression (Fig. 3, E and F). This evidence concerns the gene ATXN3 and malignant colon neoplasm.